Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
Clinical Pharmacology And Therapeutics
Yee, Sook Wah SW; Brackman, Deanna J DJ; Ennis, Elizabeth A EA; Sugiyama, Yuichi Y; Kamdem, Landry K LK; Blanchard, Rebecca R; Galetin, Aleksandra A; Zhang, Lei L; Giacomini, Kathleen M KM
Characterization of ADME gene variation in 21 populations by exome sequencing.
Pharmacogenetics And Genomics
Hovelson, Daniel H DH; Xue, Zhengyu Z; Zawistowski, Matthew M; Ehm, Margaret G MG; Harris, Elizabeth C EC; Stocker, Sophie L SL; Gross, Annette S AS; Jang, In-Jin IJ; Ieiri, Ichiro I; Lee, Jong-Eun JE; Cardon, Lon R LR; Chissoe, Stephanie L SL; Abecasis, Gonçalo G; Nelson, Matthew R MR
Publication Date: 2017-03
Variant appearance in text: SLC47A2: Pro162Leu; rs146901447
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.
Clinical Pharmacology And Therapeutics
Stocker, S L SL; Morrissey, K M KM; Yee, S W SW; Castro, R A RA; Xu, L L; Dahlin, A A; Ramirez, A H AH; Roden, D M DM; Wilke, R A RA; McCarty, C A CA; Davis, R L RL; Brett, C M CM; Giacomini, K M KM
A common 5'-UTR variant in MATE2-K is associated with poor response to metformin.
Clinical Pharmacology And Therapeutics
Choi, J H JH; Yee, S W SW; Ramirez, A H AH; Morrissey, K M KM; Jang, G H GH; Joski, P J PJ; Mefford, J A JA; Hesselson, S E SE; Schlessinger, A A; Jenkins, G G; Castro, R A RA; Johns, S J SJ; Stryke, D D; Sali, A A; Ferrin, T E TE; Witte, J S JS; Kwok, P-Y PY; Roden, D M DM; Wilke, R A RA; McCarty, C A CA; Davis, R L RL; Giacomini, K M KM